Digitisation | July 26, 2023
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
The VITA-FAST tokens have been met with overwhelming interest
Survodutide has a novel mechanism of action (agonism of the dual GCG/GLP-1 receptors) that may have direct effects on energy expenditure in the liver in addition to decreasing appetite
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
Subscribe To Our Newsletter & Stay Updated
